Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP658524.RAsSaXMgP4D-Quk5HpTEnleeAzRp1tC7M4xRrH9eK8eD4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP658524.RAsSaXMgP4D-Quk5HpTEnleeAzRp1tC7M4xRrH9eK8eD4130_assertion type Assertion NP658524.RAsSaXMgP4D-Quk5HpTEnleeAzRp1tC7M4xRrH9eK8eD4130_head.
- NP658524.RAsSaXMgP4D-Quk5HpTEnleeAzRp1tC7M4xRrH9eK8eD4130_assertion description "[The presence of HPV-18 genotype and an elevated VEGF expression appear to be poor prognostic factors in women with early disease treated with primary surgery, whereas the expression of EGFR, VEGF, COX-2 and tumor hypoxia may have a major impact on the survival of patients treated with definitive radiotherapy or chemoradiation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP658524.RAsSaXMgP4D-Quk5HpTEnleeAzRp1tC7M4xRrH9eK8eD4130_provenance.
- NP658524.RAsSaXMgP4D-Quk5HpTEnleeAzRp1tC7M4xRrH9eK8eD4130_assertion evidence source_evidence_literature NP658524.RAsSaXMgP4D-Quk5HpTEnleeAzRp1tC7M4xRrH9eK8eD4130_provenance.
- NP658524.RAsSaXMgP4D-Quk5HpTEnleeAzRp1tC7M4xRrH9eK8eD4130_assertion SIO_000772 23031678 NP658524.RAsSaXMgP4D-Quk5HpTEnleeAzRp1tC7M4xRrH9eK8eD4130_provenance.
- NP658524.RAsSaXMgP4D-Quk5HpTEnleeAzRp1tC7M4xRrH9eK8eD4130_assertion wasDerivedFrom befree-20150227 NP658524.RAsSaXMgP4D-Quk5HpTEnleeAzRp1tC7M4xRrH9eK8eD4130_provenance.
- NP658524.RAsSaXMgP4D-Quk5HpTEnleeAzRp1tC7M4xRrH9eK8eD4130_assertion wasGeneratedBy ECO_0000203 NP658524.RAsSaXMgP4D-Quk5HpTEnleeAzRp1tC7M4xRrH9eK8eD4130_provenance.